Email updates

Keep up to date with the latest news and content from BMC Medicine and BioMed Central.

Journal App

google play app store
Open Access Highly Accessed Debate

What is the future of targeted therapy in rheumatology: biologics or small molecules?

Attila Mócsai*, László Kovács and Péter Gergely

BMC Medicine 2014, 12:43  doi:10.1186/1741-7015-12-43

Article Metrics

4754
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 339 accesses
  • Last 365 days: 4754 accesses
  • All time: 4754 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information